PFO
PRTA icon

Pathstone Family Office’s Prothena Corp PRTA Stock Holding History

Pathstone Family Office’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-80
Closed -$1K – 917
2020
Q1 		$1K Buy
+80
New +$969 ﹤0.01% 728

Other funds holding PRTA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pathstone Family Office's PRTA Position: Q2 2020 in Review

Pathstone Family Office sold out of Prothena Corp (PRTA) in Q2 2020, closing a stake of 80 shares — an estimated $1K sold.

Pathstone Family Office first reported a position in PRTA in Q1 2020 and held it in 1 quarter. The position peaked at $1K in Q1 2020. 139 funds tracked by Wall St. Rank hold PRTA as of Q2 2020.

  • Pathstone Family Office reported no remaining Prothena Corp position as of Q2 2020 after selling out during the quarter.
  • Pathstone Family Office sold 80 Prothena Corp shares in Q2 2020, an estimated $1K.
  • Pathstone Family Office first reported a position in Prothena Corp in Q1 2020 and held it in 1 quarter.
  • Pathstone Family Office's Prothena Corp position peaked at $1K in Q1 2020.
  • 139 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2020.

Based on Pathstone Family Office's 13F filing for Q2 2020, filed 14 Aug 2020.